U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H20F2N4O2
Molecular Weight 410.4166
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEMBOREXANT

SMILES

CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC3=NC=C(F)C=C3)C4=CC=CC(F)=C4)C(C)=N1

InChI

InChIKey=MUGXRYIUWFITCP-PGRDOPGGSA-N
InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
LEMBOREXANT
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
LEMBOREXANT [JAN]
Common Name English
DAYVIGO
Brand Name English
(1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide
Systematic Name English
(1R,2S)-2-((2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE
Systematic Name English
LEMBOREXANT [ORANGE BOOK]
Common Name English
Lemborexant [WHO-DD]
Common Name English
CYCLOPROPANECARBOXAMIDE, 2-(((2,4-DIMETHYL-5-PYRIMIDINYL)OXY)METHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUORO-2-PYRIDINYL)-, (1R,2S)-
Systematic Name English
LEMBOREXANT [MI]
Common Name English
E2006
Code English
lemborexant [INN]
Common Name English
E-2006
Code English
LEMBOREXANT [USAN]
Common Name English
Classification Tree Code System Code
DEA NO. 2245
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
Code System Code Type Description
INN
9988
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
DAILYMED
0K5743G68X
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
EPA CompTox
DTXSID401027940
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
RXCUI
2272403
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
ChEMBL
CHEMBL3545367
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
FDA UNII
0K5743G68X
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
CAS
1369764-02-2
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
SMS_ID
100000175741
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
USAN
CD-24
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
LACTMED
Lemborexant
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
DRUG CENTRAL
5360
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
DRUG BANK
DB11951
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
WIKIPEDIA
Lemborexant
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
NCI_THESAURUS
C166424
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
MERCK INDEX
m12187
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
PUBCHEM
56944144
Created by admin on Fri Dec 15 16:45:47 UTC 2023 , Edited by admin on Fri Dec 15 16:45:47 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of LEMBOREXANT
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966